Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
We have isolated Xenopus p28Kix1, a member of the p21CIP1/p27KIP1/p57KIP2 family of cyclin-dependent kinase (Cdk) inhibitors. Members of this family negatively regulate cell cycle progression in mammalian cells by inhibiting the activities of Cdks. p28 shows significant sequence homology with p21, p27, and p57 in its N-terminal region, where the Cdk inhibition domain is known to reside. In contrast, the C-terminal domain of p28 is distinct from that of p21, p27, and p57. In co-immunoprecipitation experiments, p28 was found to be associated with Cdk2, cyclin E, and cyclin A, but not the Cdc2/cyclin B complex in Xenopus egg extracts. Xenopus p28 associates with the proliferating cell nuclear antigen, but with a substantially lower affinity than human p21. In kinase assays with recombinant Cdks, p28 inhibits pre-activated Cdk2/cyclin E and Cdk2/cyclin A, but not Cdc2/cyclin B. However, at high concentrations, p28 does prevent the activation of Cdc2/cyclin B by the Cdk-activating kinase. Consistent with the role of p28 as a Cdk inhibitor, recombinant p28 elicits an inhibition of both DNA replication and mitosis upon addition to egg extracts, indicating that it can regulate multiple cell cycle transitions. The level of p28 protein shows a dramatic developmental profile: it is low in Xenopus oocytes, eggs, and embryos up to stage 11, but increases approximately 100-fold between stages 12 and 13, and remains high thereafter. The induction of p28 expression temporally coincides with late gastrulation. Thus, although p28 may play only a limited role during the early embryonic cleavages, it may function later in development to establish a somatic type of cell cycle. Taken together, our results indicate that Xenopus p28 is a new member of the p21/p27/p57 class of Cdk inhibitors, and that it may play a role in developmental processes.
Aprelikova,
Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
1995, Pubmed
Aprelikova,
Both p16 and p21 families of cyclin-dependent kinase (CDK) inhibitors block the phosphorylation of cyclin-dependent kinases by the CDK-activating kinase.
1995,
Pubmed Chan,
Identification of human and mouse p19, a novel CDK4 and CDK6 inhibitor with homology to p16ink4.
1995,
Pubmed Chen,
Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
1995,
Pubmed
,
Xenbase Chitnis,
Primary neurogenesis in Xenopus embryos regulated by a homologue of the Drosophila neurogenic gene Delta.
1995,
Pubmed
,
Xenbase Coleman,
Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer.
1993,
Pubmed Cyert,
Regulation of MPF activity in vitro.
1988,
Pubmed
,
Xenbase Dasso,
Completion of DNA replication is monitored by a feedback system that controls the initiation of mitosis in vitro: studies in Xenopus.
1990,
Pubmed
,
Xenbase Deng,
Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.
1995,
Pubmed Desai,
Activation of human cyclin-dependent kinases in vitro.
1992,
Pubmed Dingwall,
Nuclear targeting sequences--a consensus?
1991,
Pubmed Draetta,
Cdc2 activation: the interplay of cyclin binding and Thr161 phosphorylation.
1993,
Pubmed Dunphy,
Fission yeast p13 blocks mitotic activation and tyrosine dephosphorylation of the Xenopus cdc2 protein kinase.
1989,
Pubmed
,
Xenbase el-Deiry,
WAF1, a potential mediator of p53 tumor suppression.
1993,
Pubmed Elledge,
Cdk inhibitors: on the threshold of checkpoints and development.
1994,
Pubmed Fangman,
A question of time: replication origins of eukaryotic chromosomes.
1992,
Pubmed Gu,
Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit.
1993,
Pubmed Guan,
Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.
1994,
Pubmed Halevy,
Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.
1995,
Pubmed Hannon,
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest.
1994,
Pubmed Harper,
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
1993,
Pubmed Harper,
Inhibition of cyclin-dependent kinases by p21.
1995,
Pubmed Hartenstein,
Early neurogenesis in Xenopus: the spatio-temporal pattern of proliferation and cell lineages in the embryonic spinal cord.
1989,
Pubmed
,
Xenbase Howe,
Identification of a developmental timer regulating the stability of embryonic cyclin A and a new somatic A-type cyclin at gastrulation.
1995,
Pubmed
,
Xenbase Jackson,
Early events in DNA replication require cyclin E and are blocked by p21CIP1.
1995,
Pubmed
,
Xenbase Kato,
Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation.
1994,
Pubmed Koff,
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle.
1992,
Pubmed Kumagai,
The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system.
1991,
Pubmed
,
Xenbase Kumagai,
Control of the Cdc2/cyclin B complex in Xenopus egg extracts arrested at a G2/M checkpoint with DNA synthesis inhibitors.
1995,
Pubmed
,
Xenbase Lee,
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.
1995,
Pubmed Leno,
DNA replication in cell-free extracts from Xenopus laevis.
1991,
Pubmed
,
Xenbase Li,
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair.
1994,
Pubmed Luo,
Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1.
1995,
Pubmed Massagué,
Mammalian antiproliferative signals and their targets.
1995,
Pubmed Matsuoka,
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene.
1995,
Pubmed Minshull,
A MAP kinase-dependent spindle assembly checkpoint in Xenopus egg extracts.
1994,
Pubmed
,
Xenbase Mueller,
Cell cycle regulation of a Xenopus Wee1-like kinase.
1995,
Pubmed
,
Xenbase Murray,
Cell cycle extracts.
1991,
Pubmed Newport,
A major developmental transition in early Xenopus embryos: I. characterization and timing of cellular changes at the midblastula stage.
1982,
Pubmed
,
Xenbase Newport,
A major developmental transition in early Xenopus embryos: II. Control of the onset of transcription.
1982,
Pubmed
,
Xenbase Noda,
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen.
1994,
Pubmed Nourse,
Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin.
1994,
Pubmed Pagano,
Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.
1995,
Pubmed Parker,
p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells.
1995,
Pubmed Polyak,
p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.
1994,
Pubmed Polyak,
Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.
1994,
Pubmed Rempel,
Maternal Xenopus Cdk2-cyclin E complexes function during meiotic and early embryonic cell cycles that lack a G1 phase.
1995,
Pubmed
,
Xenbase Serrano,
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
1993,
Pubmed Sherr,
Mammalian G1 cyclins.
1993,
Pubmed Smith,
Xenopus cell lines.
1991,
Pubmed
,
Xenbase Su,
Cloning and characterization of the Xenopus cyclin-dependent kinase inhibitor p27XIC1.
1995,
Pubmed
,
Xenbase Tang,
Two distinct mechanisms for negative regulation of the Wee1 protein kinase.
1993,
Pubmed
,
Xenbase Toyoshima,
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.
1994,
Pubmed Waga,
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA.
1994,
Pubmed Warbrick,
A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen.
1995,
Pubmed Xiong,
p21 is a universal inhibitor of cyclin kinases.
1993,
Pubmed Yan,
An analysis of the regulation of DNA synthesis by cdk2, Cip1, and licensing factor.
1995,
Pubmed
,
Xenbase Zhang,
p21-containing cyclin kinases exist in both active and inactive states.
1994,
Pubmed
